Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Southridge Capital Management is a diversified financial services firm that provides investment management and advisory services, with a significant history of financing micro-cap companies in the life sciences and healthcare sectors. Founded in 1996 by Stephen Hicks, the firm specializes in structured finance, including direct investment through equity lines and convertible securities. Southridge has provided essential capital to numerous emerging biotechnology companies to support their research, development, and clinical trial processes. The firm operates primarily as a source of alternative funding for public companies that may have limited access to traditional institutional capital. Its investment portfolio has historically spanned various industries, but it is particularly noted for its activity in the small-cap biotech space. Through its various funds, Southridge has facilitated hundreds of millions of dollars in financing for its portfolio companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Southridge Capital Management.